Human Genome (HGSI) surges 98% to $14.20 premarket after it reveals it rejected an offer of...

|By:, SA News Editor

Human Genome (HGSI) surges 98% to $14.20 premarket after it reveals it rejected an offer of $13/share from GSK and that it's carrying out a strategic review.